Haemonetics Corp Reports FY2026 Q4 and Full-Year Financial Results

What Happened Haemonetics Corporation announced on May 7, 2026 that it issued a press release reporting its financial results for the fourth quarter and fiscal year ended March 28, 2026. The company furnished that press release as Exhibit 99.1 to the Form 8-K (filed May 7, 2026), and the report was signed by President and CEO Christopher A. Simon.

Key Details

• Event: Press release announcing Q4 and fiscal year 2026 financial results (furnished on Form 8-K, Item 2.02).
• Date filed: May 7, 2026.
• Fiscal period: Quarter and fiscal year ended March 28, 2026.
• Exhibit: Press release included as Exhibit 99.1 to the 8-K.

Why It Matters Earnings press releases contain the company’s revenue, earnings, and other operating metrics that can affect Haemonetics’ stock price and investor decisions. This 8-K indicates Haemonetics publicly released its quarterly and annual results; investors should review the attached press release (Exhibit 99.1) and related quarterly filings or earnings call materials for the detailed figures, trends and any management commentary.